CRISPR Therapeutics AG Underwriting Agreements
5 Contracts & Agreements
- Underwriting Agreement, dated as of June 30, 2020, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the... (Filed With SEC on July 2, 2020)
- Underwriting Agreement, dated as of November 20, 2019, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Jefferies LLC, as representatives of the... (Filed With SEC on November 22, 2019)
- Underwriting Agreement, dated as of September 20, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc. as representatives... (Filed With SEC on September 21, 2018)
- Underwriting Agreement, dated as of January 4, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc., as representatives of... (Filed With SEC on January 5, 2018)
- CRISPR THERAPEUTICS AG Common Shares (nominal value CHF 0.03 per share) Underwriting Agreement (Filed With SEC on October 7, 2016)
